115 related articles for article (PubMed ID: 1784590)
1. Modulation of the dose-dependent effects of atropine by low-dose pyridostigmine: quantification by spectral analysis of heart rate fluctuations in healthy human beings.
Izraeli S; Alcalay M; Benjamini Y; Wallach-Kapon R; Tochner Z; Akselrod S
Pharmacol Biochem Behav; 1991 Jul; 39(3):613-7. PubMed ID: 1784590
[TBL] [Abstract][Full Text] [Related]
2. Subacute pyridostigmine exposure increases heart rate recovery and cardiac parasympathetic tone in rats.
Bharadwaj M; Pope C; Davis M; Katz S; Cook C; Maxwell L
Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):872-879. PubMed ID: 28440910
[TBL] [Abstract][Full Text] [Related]
3. Quantifying the altered cardiac response to atropine following pyridostigmine in rhesus macaques.
Birnbaum SG; Richardson BC; Dellinger JA
Pharmacol Biochem Behav; 1988 Oct; 31(2):381-6. PubMed ID: 3244715
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological modulation of vagal cardiac control measured by heart rate power spectrum: a possible bioequivalent probe.
Alcalay M; Izraeli S; Wallach-Kapon R; Tochner Z; Benjamini Y; Akselrod S
Neurosci Biobehav Rev; 1991; 15(1):51-5. PubMed ID: 2052198
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical pharmacodynamic effect of atropine on parasympathetic control: a study by spectral analysis of heart rate fluctuations.
Alcalay M; Izraeli S; Wallach-Kapon R; Tochner Z; Benjamini Y; Akselrod S
Clin Pharmacol Ther; 1992 Nov; 52(5):518-27. PubMed ID: 1424426
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects.
Nóbrega AC; dos Reis AF; Moraes RS; Bastos BG; Ferlin EL; Ribeiro JP
Clin Auton Res; 2001 Feb; 11(1):11-7. PubMed ID: 11503945
[TBL] [Abstract][Full Text] [Related]
7. Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats.
Soares PP; da Nóbrega AC; Ushizima MR; Irigoyen MC
Auton Neurosci; 2004 Jun; 113(1-2):24-31. PubMed ID: 15296792
[TBL] [Abstract][Full Text] [Related]
8. Parasympathetic activation by pyridostigmine on chemoreflex sensitivity in heart-failure rats.
Sabino JP; da Silva CA; Giusti H; Glass ML; Salgado HC; Fazan R
Auton Neurosci; 2013 Dec; 179(1-2):43-8. PubMed ID: 23911533
[TBL] [Abstract][Full Text] [Related]
9. Effect of pyridostigmine pretreatment on cardiorespiratory function in tabun poisoning.
Worek F; Kleine A; Szinicz L
Hum Exp Toxicol; 1995 Aug; 14(8):634-42. PubMed ID: 7576830
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic stimulation with pyridostigmine protects myocardial infarcted rats against ischemic-induced arrhythmias and preserves connexin43 protein.
Santos-Almeida FM; Girão H; da Silva CA; Salgado HC; Fazan R
Am J Physiol Heart Circ Physiol; 2015 Jan; 308(2):H101-7. PubMed ID: 25416192
[TBL] [Abstract][Full Text] [Related]
11. Exercise stress testing in healthy subjects during cholinergic stimulation after a single dose of pyridostigmine.
Serra SM; Costa RV; Bastos BG; Bousquet Santos K; Ramalho SH; da Nóbrega AC
Arq Bras Cardiol; 2001 Apr; 76(4):279-84. PubMed ID: 11323731
[TBL] [Abstract][Full Text] [Related]
12. Increase in parasympathetic tone by pyridostigmine prevents ventricular dysfunction during the onset of heart failure.
Lataro RM; Silva CA; Fazan R; Rossi MA; Prado CM; Godinho RO; Salgado HC
Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(8):R908-16. PubMed ID: 23948774
[TBL] [Abstract][Full Text] [Related]
13. Vagal tone monitoring: a potential indicator of anti-cholinesterase exposure in Macaca mulatta.
Dellinger JA; Jansen HT; Zaber DJ; Birnbaum SG
Toxicology; 1988 May; 49(2-3):227-35. PubMed ID: 3376129
[TBL] [Abstract][Full Text] [Related]
14. The effect of pyridostigmine on respiratory function in healthy and asthmatic volunteers.
Ram Z; Molcho M; Danon YL; Almog S; Baniel J; Karni A; Shemer J
Isr J Med Sci; 1991; 27(11-12):664-8. PubMed ID: 1757243
[TBL] [Abstract][Full Text] [Related]
15. Effect of acetylcholinesterase inhibition with pyridostigmine on cardiac parasympathetic function in sedentary adults and trained athletes.
Dewland TA; Androne AS; Lee FA; Lampert RJ; Katz SD
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H86-92. PubMed ID: 17322413
[TBL] [Abstract][Full Text] [Related]
16. Cumulative plot of heart rate variability spectrum assesses kinetics of action of cholinergic drugs in rats.
Perlstein I; Hoffman A
Am J Physiol Heart Circ Physiol; 2000 Jul; 279(1):H110-5. PubMed ID: 10899047
[TBL] [Abstract][Full Text] [Related]
17. Cholinergic stimulation with pyridostigmine reduces the QTc interval in coronary artery disease.
Castro RR; Porphirio G; Serra SM; Nóbrega AC
Braz J Med Biol Res; 2002 Jun; 35(6):685-9. PubMed ID: 12045833
[TBL] [Abstract][Full Text] [Related]
18. The effect on heart rate of neuromuscular blockade reversal by pyridostigmine.
Long G; Marsh HM
Anaesth Intensive Care; 1981 May; 9(2):144-6. PubMed ID: 7258611
[TBL] [Abstract][Full Text] [Related]
19. Effect of low-dose atropine on heart rate fluctuations during orthostatic load: a spectral analysis.
Weise F; Baltrusch K; Heydenreich F
J Auton Nerv Syst; 1989 Apr; 26(3):223-30. PubMed ID: 2754178
[TBL] [Abstract][Full Text] [Related]
20. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure.
Behling A; Moraes RS; Rohde LE; Ferlin EL; Nóbrega AC; Ribeiro JP
Am Heart J; 2003 Sep; 146(3):494-500. PubMed ID: 12947369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
